MedTrace Logo

Clinical Characteristics and Genetic Profiles of Severe Combined Immunodeficiency in China

NCT02231983 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2014-09-04

No results posted yet for this study

Summary

Severe combined immunodeficiency (SCID), a rare primary immunodeficiency dieases (PID), is poorly characterized in mainland China. We meant to explore the patients with SCID refered to our hospital and summarize their clinical manifestations and genetic features.

Conditions

  • Severe Combined Immunodeficiency

Interventions

GENETIC

gene sequencing

Amplify and identify exons from gene IL-2RG by PCR and agarose gel electrophoresis, and then followed by gene sequencing.

Sponsors & Collaborators

  • Shanghai Children's Medical Center

    lead OTHER

Eligibility

Min Age
2 Months
Max Age
2 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-09-30
Primary Completion
2016-09-30
Completion
2016-09-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02231983 on ClinicalTrials.gov